Previously, we discovered that C4d, but not C3 or C4, was an accurate marker to distinguish between remission and flare, as well as to predict future LN flares in relapsing patients in a cross-sectional SLE cohort (8). The gene discussed is C4A; the disease is systemic lupus erythematosus.